Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
05 Jul 2023, 21:47:45 UTC
Prior SEC filing
23 Jun 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Bradley Tank by his Attorney-in-Fact, Jennifer R. Gonzalez
Filing notes and source

Key filing fact

Bradley Tank filed Form 4 for Neuberger Berman High Yield Strategies Fund Inc. (NHS) on 05 Jul 2023.

Key facts

  • This page summarizes Bradley Tank's Form 4 filing for Neuberger Berman High Yield Strategies Fund Inc. (NHS).
  • 6 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 05 Jul 2023, 21:47.

Change

  • Previous filing in this sequence was filed on 23 Jun 2023.
  • Current net transaction value: +$887,788.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NHS transaction

Common Stock

Exercise of in-the-money or at-the-money derivative security

Transaction value
$500,642
Shares
+67,472
Change %
+50%
Price
$7.42
Shares after
202,412
Date
03 Jul 2023
Ownership
Direct
Footnotes
F1, F2, F3, F4
NHS transaction

Common Stock

Exercise of in-the-money or at-the-money derivative security

Transaction value
$342,418
Shares
+46,148
Change %
+50%
Price
$7.42
Shares after
138,443
Date
03 Jul 2023
Ownership
By Indian Hill II LLC
Footnotes
F1, F2, F3, F4, F5
NHS transaction

Common Stock

Exercise of in-the-money or at-the-money derivative security

Transaction value
$44,728
Shares
+6,028
Change %
+50%
Price
$7.42
Shares after
18,082
Date
03 Jul 2023
Ownership
By Brad C Tank 1999 Trust
Footnotes
F1, F2, F3, F4, F5

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NHS transaction Derivative

Oversubscription Privilege (contingent right to buy)

Exercise of in-the-money or at-the-money derivative security

Transaction value
Shares
-67,472
Change %
-100%
Price
Shares after
0
Date
03 Jul 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
67,472
Exercise price
Footnotes
F1, F2, F3, F4
NHS transaction Derivative

Oversubscription Privilege (contingent right to buy)

Exercise of in-the-money or at-the-money derivative security

Transaction value
Shares
-46,148
Change %
-100%
Price
Shares after
0
Date
03 Jul 2023
Ownership
By Indian Hill II LLC
Underlying class
Common Stock
Underlying amount
46,148
Exercise price
Footnotes
F1, F2, F3, F4, F5
NHS transaction Derivative

Oversubscription Privilege (contingent right to buy)

Exercise of in-the-money or at-the-money derivative security

Transaction value
Shares
-6,028
Change %
-100%
Price
Shares after
0
Date
03 Jul 2023
Ownership
By Brad C Tank 1999 Trust
Underlying class
Common Stock
Underlying amount
6,028
Exercise price
Footnotes
F1, F2, F3, F4, F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Neuberger Berman High Yield Strategies Fund Inc. (the "Fund") recently completed a pro rata offering (the "Rights Offering") of transferable subscription rights ("Rights") to its common stockholders of record as of the close of business on May 23, 2023 (the "Record Date Stockholder") entitling the holders of such Rights to purchase additional shares of common stock of the Fund (the "Common Stock"). Record Date Stockholders received one Right for each outstanding whole share of Common Stock held on the record date. The Rights entitled their holders to purchase one new share of Common Stock for every three Rights held at a discount to the market price of the Common Stock. The subscription price per share of Common Stock was $7.42 (the "basic subscription privilege").

Footnote F2

Record Date Stockholders who fully exercised their Rights were entitled to subscribe, subject to certain limitations and subject to allotment, for additional shares of Common Stock which were not subscribed for (the "Over-Subscription Privilege"). The reporting person fully exercised all Rights received and subscribed for additional shares of Common Stock pursuant to the Over-Subscription Privilege, subject to the pro rata allocation of available shares of Common Stock. Fractional shares of Common Stock were not issued. The subscription period commenced on May 23, 2023 and expired on June 21, 2023.

Footnote F3

Following the conclusion of the Rights Offering, the shares of Common Stock that were not subscribed for by the holders of Rights in the basic subscription privilege were allocated pro rata among Rights holders that exercised their Over-Subscription Privilege based on the number of shares of Common Stock each of those Rights holders owned on the record date and subject to the amount of shares of Common Stock such holder subscribed for.

Footnote F4

The reporting person purchased 59,824 shares of Common Stock from the exercise of his rights in the basic subscription privilege (previously reported in a Form 4 filed on June 23, 2023), plus an additional 119,648 shares of Common Stock pursuant to the Over-Subscription Privilege associated with the reporting person's subscription rights on the basis of the Fund's allocation of shares of Common Stock after the close of the subscription period. On July 3, 2023, the third-party subscription agent for the Rights Offering determined the allocations to be made to the Record Date Stockholders who exercised their Over-Subscription Privilege. The Common Stock subscribed for will be issued after receipt of all stockholder payments.

Footnote F5

The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .